Position in NSRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$86,351
New position
Shares Held
38,897
first reported quarter
Ownership
0.332%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 9 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. NSRX ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
926,410 | $201,484,910 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,075,945 | $125,906,064 | |
| 3 | AMGN |
Amgen Inc
|
321,715 | $113,195,422 | |
| 4 | LLY |
ELI LILLY & Co
|
53,051 | $48,794,718 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
270,699 | $37,727,319 | |
| 6 | GSK |
GSK plc
|
425,687 | $23,493,665 | |
| 7 | MRK |
Merck & Co., Inc.
|
142,729 | $17,168,871 | |
| 8 | NVS |
Novartis AG
|
24,886 | $3,801,336 |
All Filings in NSRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $86,351 | 38,897 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||